Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078418 | SCV000110264 | benign | not specified | 2013-06-06 | criteria provided, single submitter | clinical testing | |
Genomic Diagnostic Laboratory, |
RCV000030216 | SCV000296889 | benign | Lynch syndrome | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000579850 | SCV000684767 | benign | Hereditary cancer-predisposing syndrome | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000078418 | SCV000805955 | benign | not specified | 2016-12-19 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000987182 | SCV001136421 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001521972 | SCV001731413 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001689577 | SCV001915401 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 21056691) |
Sema4, |
RCV000579850 | SCV002528670 | benign | Hereditary cancer-predisposing syndrome | 2020-03-26 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV000579850 | SCV002713766 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001689577 | SCV004011453 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | MLH1: BS1, BS2 |
CHEO Genetics Diagnostic Laboratory, |
RCV003492304 | SCV004240748 | benign | Breast and/or ovarian cancer | 2022-09-14 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000078418 | SCV004243151 | benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001689577 | SCV005258450 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030216 | SCV000052883 | benign | Lynch syndrome | 2012-08-02 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000078418 | SCV000257063 | uncertain significance | not specified | no assertion criteria provided | research | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000078418 | SCV001799213 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000078418 | SCV001808119 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV001689577 | SCV001905883 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000078418 | SCV001925517 | benign | not specified | no assertion criteria provided | clinical testing |